Učitavanje...
Potential for immunotherapy in soft tissue sarcoma
Soft tissue sarcomas (STS) are rare, heterogeneous tumors of mesenchymal origin. Despite optimal treatment, a large proportion of patients will develop recurrent and metastatic disease. For these patients, current treatment options are quite limited. Significant progress has been made recently in th...
Spremljeno u:
| Izdano u: | Hum Vaccin Immunother |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514087/ https://ncbi.nlm.nih.gov/pubmed/25625925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.983003 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|